Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples